Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Hypoxia 1

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 6pimonidazole 4fluoroazomycin arabinoside 4TH 302 4Radiotherapy 4Propofol 3Injections 3Positron Emission Tomography Computed Tomography 2Drug Therapy 2Blood Specimen Collection 2Bacterial Load 2pomalidomide 1pembrolizumab 1inositol trispyrophosphate 1gadobutrol 1fluoromisonidazole 1fludarabine 1alovudine 1Tirapazamine 1Thoracotomy 1Thoracic Surgery, Video-Assisted 1Temozolomide 1Surgical Procedures, Operative 1Sodium Chloride 1Sevoflurane 1Saline Solution 1Pancreaticoduodenectomy 1Paclitaxel 1Oxygen 1Nitroglycerin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypoxia × 4-methylbenzenesulfonic acid × Clear all
NCT04727034 2022-10-12

Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy

RenJi Hospital

Phase NA Unknown
1,800 enrolled
Gastrointestinal

Hypoxia, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡